Haleon Plc (HLN) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Haleon Plc (HLN) stock forecast summary
Our AI ranks Haleon Plc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for HLN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HLN included.
Follow HLN freeHLN price chart and AI forecast
How HLN ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Haleon Plc (HLN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
HLN quarterly financials and insider trading
Haleon Plc (HLN) industry peers
Companies classified under the same SEC industry code as Haleon Plc (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| HLN Haleon Plc | ▼ | N/A |
| CL Colgate Palmolive Co | ▼ | $71.71B |
| EL Estee Lauder Companies Inc | ▼ | $36.08B |
| KVUE Kenvue Inc. | ▼ | $34.11B |
| ELF E.L.F. Beauty, Inc. | ▶ | $6.38B |
| IPAR Interparfums Inc | ▼ | $3.65B |
| COTY Coty Inc. | ▲ | $2.60B |
| EPC Edgewell Personal Care Co | ▼ | $1.31B |
| WALD Waldencast Plc | ▲ | $86M |
| SLSN Solesence, Inc. | ▲ | $71M |
| SHFH Scientist Home Future Health Ltd | ▼ | $40M |
| AXIL Axil Brands, Inc. | ▶ | $39M |
| UG United Guardian Inc | ▲ | $32M |
| DQWS Dswiss Inc | ▼ | $17M |
| CABR Caring Brands, Inc. | ▲ | $13M |
| BNKK Bonk, Inc. | ▲ | $11M |
| YCBD Cbdmd, Inc. | ▲ | $4M |
| KARX Karbon-X Corp. | ▼ | N/A |
| ODD Oddity Tech Ltd | ▶ | N/A |
Where HLN sits on the market map
Haleon Plc (HLN) stock news
Loading...
Haleon Plc (HLN) stock forecast FAQ
What is the Haleon Plc (HLN) stock forecast?
Our AI ranks Haleon Plc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Haleon Plc stock predictions?
A per-ticker accuracy statistic for HLN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Haleon Plc forecasts updated?
Haleon Plc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Haleon Plc's industry peers?
19 issuers in our coverage, HLN included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.